93
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Exposure to naphthalene induces naphthyl-keratin adducts in human epidermis in vitro and in vivo

, , &
Pages 488-497 | Received 24 Feb 2010, Accepted 12 Apr 2010, Published online: 25 May 2010

References

  • Albers K, Fuchs E. (1992). The molecular biology of intermediate filament proteins. Int Rev Cytol 134:243–79.
  • Alexandrie AK, Warholm M, Carstensen U, Axmon A, Hagmar L, Levin JO, Ostman C, Rannug A. (2000). CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 21:669–76.
  • Baron JM, Holler D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert FK. (2001). Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541–8.
  • Baron JM, Merk HF. (2001). Drug metabolism in the skin. Curr Opin Allergy Clin Immunol 1:287–91.
  • Carlton GN, Smith LB. (2000). Exposures to jet fuel and benzene during aircraft fuel tank repair in the U.S. Air Force. Appl Occup Environ Hyg 15:485–91.
  • Chao YC, Gibson RL, Nylander-French LA. (2005). Dermal exposure to jet fuel (JP-8) in US Air Force personnel. Ann Occup Hyg 49:639–45.
  • Chao YC, Kupper LL, Serdar B, Egeghy PP, Rappaport SM, Nylander-French LA. (2006). Dermal exposure to jet fuel JP-8 significantly contributes to the production of urinary naphthols in fuel-cell maintenance workers. Environ Health Perspect 114:182–5.
  • DFG. (2008). List of MAK and BAT Values 2008: Maximum Concentrations and Biological Tolerance Values at the Workplace. Report 44. Oxford: Wiley, John & Sons.
  • Du L, Hoffman SM, Keeney DS. (2004). Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol 195:278–87.
  • Egeghy PP, Hauf-Cabalo L, Gibson R, Rappaport SM. (2003). Benzene and naphthalene in air and breath as indicators of exposure to jet fuel. Occup Environ Med 60:969–76.
  • Eichner R, Sun TT, Aebi U. (1986). The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J Cell Biol 102:1767–77.
  • EPA. (1998). Toxicological Review of Naphthalene (CAS No. 91-20-3) in Support of Summary Information on the Integrated Risk Information System (IRIS). Cincinnati, OH: US Environmental Protection Agency, National Center for Environmental Assessment.
  • Figueroa JD, Sakoda LC, Graubard BI, Chanock S, Rubertone MV, Erickson RL, McGlynn KA. (2008). Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes Control 19:917–29.
  • Fuchs E, Green H. (1980). Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19:1033–42.
  • Furukawa F, Kanehara S, Harano F, Shinohara S, Kamimura J, Kawabata S, Igarashi S, Kawamura M, Yamamoto Y, Miyachi Y. (2008). Effects of adenosine 5′-monophosphate on epidermal turnover. Arch Dermatol Res 300:485–93.
  • Gabbani G, Pavanello S, Nardini B, Tognato O, Bordin A, Fornasa CV, Bezze G, Clonfero E. (1999). Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar. Mutat Res 440:27–33.
  • Ghetti G, Mariani L. (1956). [Ocular changes caused by naphthalene; clinical and experimental studies.]. Med Lav 47:533–8.
  • Gibbs S, van de Sandt JJ, Merk HF, Lockley DJ, Pendlington RU, Pease CK. (2007). Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr Drug Metab 8:758–72.
  • Godschalk RW, Ostertag JU, Zandsteeg AM, Van Agen B, Neuman HA, Van Straaten H, Van Schooten FJ. (2001). Impact of GSTM1 on aromatic-DNA adducts and p53 accumulation in human skin and lymphocytes. Pharmacogenetics 11:537–43.
  • IARC. (2002). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum 82:1–556.
  • Janmohamed A, Dolphin CT, Phillips IR, Shephard EA. (2001). Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 62:777–86.
  • Jerina DM, Daly JW, Witkop B, Zaltzman-Nirenberg P, Udenfriend S. (1970). 1,2-naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9:147–56.
  • Kang-Sickel JC, Fox DD, Nam TG, Jayaraj K, Ball LM, French JE, Klapper DG, Gold A, Nylander-French LA. (2008). S-arylcysteine-keratin adducts as biomarkers of human dermal exposure to aromatic hydrocarbons. Chem Res Toxicol 21:852–8.
  • Kim D, Andersen ME, Chao YC, Egeghy PP, Rappaport SM, Nylander-French LA. (2007). PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene. Environ Health Perspect 115:894–901.
  • Kim D, Andersen ME, Nylander-French LA. (2006). Dermal absorption and penetration of jet fuel components in humans. Toxicol Lett 165:11–21.
  • Lee CY, Lee JY, Kang JW, Kim H. (2001). Effects of genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 on the urinary levels of 1-hydroxypyrene and 2-naphthol in aircraft maintenance workers. Toxicol Lett 123:115–24.
  • Majumdar S, Mondal BC, Ghosh M, Dey S, Mukhopadhyay A, Chandra S, Dasgupta UB. (2008). Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 17:125–32.
  • McDougal JN, Pollard DL, Weisman W, Garrett CM, Miller TE. (2000). Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol Sci 55:247–55.
  • Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63.
  • Nelson DR. (2002). Introductory remarks on human CYPs. Drug Metab Rev 34:1–5.
  • North DW, Abdo KM, Benson JM, Dahl AR, Morris JB, Renne R, Witschi H. (2008). A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul Toxicol Pharmacol 51(2 Suppl):S6–14.
  • NTP. (2000). Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies). Natl Toxicol Program Tech Rep Ser 500:1–173.
  • Pavek P, Dvorak Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129–43.
  • Ponec M, Boelsma E, Gibbs S, Mommaas M. (2002). Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 15 (Suppl. 1):4–17.
  • Saeki M, Saito Y, Nagano M, Teshima R, Ozawa S, Sawada J. (2002). mRNA expression of multiple cytochrome p450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 127:333–6.
  • Santhanakrishnan BR, Ranganathan G, Raju VB. (1973). Naphthalene induced haemolytic anaemia with haemoglobinuria. Indian J Pediatr 40:195–7.
  • Schweizer J, Winter H. (1983). Keratin biosynthesis in normal mouse epithelia and in squamous cell carcinomas. mRNA-dependent alterations of the primary structure of distinct keratin subunits in tumors. J Biol Chem 258:13268–72.
  • Serdar B, Egeghy PP, Gibson R, Rappaport SM. (2004). Dose-dependent production of urinary naphthols among workers exposed to jet fuel (JP-8). Am J Ind Med 46:234–44.
  • Shimada T. (2006). Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257–76.
  • Torresan C, Oliveira MM, Torrezan GT, de Oliveira SF, Abuazar CS, Losi-Guembarovski R, Lima RS, Urban CA, Cavalli IJ, Ribeiro EM. (2008). Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin Exp Med 8:65–71.
  • Waidyanatha S, Troester MA, Lindstrom AB, Rappaport SM. (2002). Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chem Biol Interact 141:189–210.
  • Waidyanatha S, Zheng Y, Serdar B, Rappaport SM. (2004). Albumin adducts of naphthalene metabolites as biomarkers of exposure to polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev 13:117–24.
  • Watt FM. (1988). Proliferation and terminal differentiation of human epidermal keratinocytes in culture. Biochem Soc Trans 16:666–8.
  • Wilson AS, Davis CD, Williams DP, Buckpitt AR, Pirmohamed M, Park BK. (1996). Characterisation of the toxic metabolite(s) of naphthalene. Toxicology 114:233–42.
  • Witzmann FA, Monteiro-Riviere NA, Inman AO, Kimpel MA, Pedrick NM, Ringham HN, Riviere JE. (2005). Effect of JP-8 jet fuel exposure on protein expression in human keratinocyte cells in culture. Toxicol Lett 160:8–21.
  • Wolf O. (1978). [Cancer of the larynx in naphthalene cleaners]. Z Gesamte Hyg 24:737–9.
  • Yang M, Koga M, Katoh T, Kawamoto T. (1999). A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Arch Environ Contam Toxicol 36:99–108.
  • Yengi LG, Xiang Q, Pan J, Scatina J, Kao J, Ball SE, Fruncillo R, Ferron G, Roland Wolf C. (2003). Quantitation of cytochrome P450 mRNA levels in human skin. Anal Biochem 316:103–10.
  • Yeowell-O’Connell K, McDonald TA, Rappaport SM. (1996). Analysis of hemoglobin adducts of benzene oxide by gas chromatography-mass spectrometry. Anal Biochem 237:49–55.
  • Zinkham WH, Childs B. (1958). A defect of glutathione metabolism in erythrocytes from patients with a naphthalene-induced hemolytic anemia. Pediatrics 22:461–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.